Staar Surgical Co's Total Assets for the quarter that ended in Mar. 2026 was $451.1 Mil.
Warning Sign:
If a company builds assets at 21.5% a year, faster than its revenue growth rate of 8.4% over the past 5 years, it means that the company may be getting less efficient.
During the past 12 months, Staar Surgical Co's average Total Assets Growth Rate was 22.40% per year.
During the past 3 years, the average Total Assets Growth Rate was 8.40% per year.
During the past 5 years, the average Total Assets Growth Rate was 21.50% per year.
During the past 10 years, the average Total Assets Growth Rate was 23.30% per year.
During the past 13 years, Staar Surgical Co's highest 3-Year average Total Assets Growth Rate was 53.50%. The lowest was -23.70%. And the median was 9.50%.
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Staar Surgical Co's Asset Turnover for the quarter that ended in Mar. 2026 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Staar Surgical Co Total Assets Related Terms
Staar Surgical Co Total Assets Historical Data
* Premium members only.
The historical data trend for Staar Surgical Co's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
Staar Surgical Co's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Staar Surgical Co (STAA) has a Total Assets of $451.1 Mil as of Mar. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on Staar Surgical Co and its competitors.
Is Staar Surgical Co's Total Assets too high?
Staar Surgical Co's current Total Assets is $451.1 Mil. Overall, Staar Surgical Co has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Staar Surgical Co's Total Assets compare to NNNN and ATRC?
Staar Surgical Co's Total Assets of $451.1 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Medical Devices & Instruments company?
A good Total Assets depends on the Medical Devices & Instruments industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Staar Surgical Co and its competitors. Staar Surgical Co's current Total Assets is $451.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Staar Surgical Co stock overvalued right now?
Based on GuruFocus' analysis, Staar Surgical Co (STAA) is currently considered Fairly Valued. The stock's GF Value™ is $31.39, compared to a current price of $29.29 — trading 6.7% below its estimated fair value. The current Total Assets is $451.1 Mil. Staar Surgical Co's overall GF Score™ is 79/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Staar Surgical Co (STAA), the current Total Assets is $451.1 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Staar Surgical Co (STAA) Overvalued in 2026?
Based on GuruFocus' analysis, Staar Surgical Co stock appears to be undervalued.
The current stock price of $29.29 is trading 6.7% below its estimated GF Value™ of $31.39.
GuruFocus considers Staar Surgical Co to be Fairly Valued.
Key valuation signals for STAA:
Total Assets: $451.1 Mil
GF Value™: $31.39 vs. price of $29.29 (6.7% below fair value)
No single metric tells the full story. See the STAA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.
79GF Score
Get the complete analysis for STAA
Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STAA has been successfully added to your 
